-
Prediction of large-for-gestational-age neonate by routine third-trimester ultrasound.
Khan N, Ciobanu A, Karampitsakos T, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2019;54:326-333. pdf -
Gestational disruptions in metabolic rhythmicity of the liver, muscle, and placenta affect fetal size.
Papacleovoulou G, Nikolova V, Oduwole O, Chambers J, Vazquez-Lopez M, Jansen E, Nicolaides K, Parker M, Williamson C.
FASEB J 2017;31:1698-1708. pdf -
Prediction of large-for-gestational-age neonates: screening by maternal factors and biomarkers in the three trimesters of pregnancy.
Frick AP, Syngelaki A, Zheng M, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2016;47:332-9. pdf -
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus.
Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, Pastides A, Shehata H.
N Engl J Med 2016;374:434-43. pdf -
Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method.
Ashoor G, Syngelaki A, Wang E, Struble C, Oliphant A, Song K, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;41:21-5. -
Maternal serum 25-hydroxyvitamin D levels at 11(+0) -13(+6) weeks in pregnant women with diabetes mellitus and in those with macrosomic neonates.
Savvidou M, Akolekar R, Samaha R, Masconi A, Nicolaides Kh.
BJOG 2011;118:951-5. -
First-trimester prediction of macrosomia.
Poon LC, Karagiannis G, Stratieva V, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2011;29:139-47. -
Maternal serum adiponectin at 11-13 weeks of gestation in predicition of macrosomia.
Nanda S, Akolekar R, Sarquis R, Mosconi AP, Nicolaides KH.
Prenat Diagn 2011;31:479-83. -
Frontomaxillary facial angle in fetuses with trisomy 13 at 11 + 0 to 13 + 6 weeks.
Borenstein M, Persico N, Dagklis T, Faros E, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:819-23. -
Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
Papageorghiou AT, Avgidou K, Spencer K, Nix B, Nicolaides KH.
Am J Obstet Gynecol 2006;194:397-401. -
Metopic suture in fetuses with Apert syndrome at 22-27 weeks of gestation.
Faro C, Chaoui R, Wegrzyn P, Levaillant JM, Benoit B, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:28-33. -
Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
Spencer K, Crossley JA, Aitken DA, Nicolaides KH.
Prenat Diagn 2005;25:358-61. -
Hypophosphatasia associated with increased nuchal translucency: a report of two affected pregnancies.
Souka AP, Raymond FL, Mornet E, Geerts L, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:294-5. -
Blackfan-Diamond anemia and dyserythropoietic anemia presenting with increased nuchal translucency at 12 weeks of gestation.
Souka AP, Bower S, Geerts L, Huggon I, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;20:197-9. -
Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta hCG and PAPP-A at 10-14 weeks of gestation.
Spencer K, Ong C, Skentou H, Liao AW, Nicolaides KH.
Prenat Diagn 2000;20:411-6. -
Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
Snijders RJ, Sebire NJ, Nayar R, Souka A, Nicolaides KH.
Am J Med Genet 1999;86:205-7. -
Diagnosis of the Meckel-Gruber syndrome at eleven to fourteen weeks gestation.
Sepulveda W, Sebire NJ, Souka A, Snijders RJ, Nicolaides KH.
Am J Obstet Gynecol 1997;176:316-9. -
Lethal congenital arthrogryposis presents with increased nuchal translucency at 10-14 weeks of gestation.
Hyett JH, Noble P, Sebire NJ, Snijders RJM, Nicolaides KH.
Ultrasound Obstet Gynecol 1997;9:310-3. -
Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome.
Hyett JA, Clayton PT, Moscoso G, Nicolaides KH.
Am J Med Genet 1995;58:374-6.